C4 Therapeutics (CCCC) Stock Highlights

3.95 | +2.6%

2024-12-21 05:36:39

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the bodys natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Statistics

Range Today

3.72 3.98

Volume Today 3.81M

Range 1 Year

3.61 11.88

Volume 1 Year 572.94M

Range 3 Year

1.06 34.64

Volume 3 Year 1.59B

Range 10 Year

1.06 51.21

Volume 10 Year 1.72B

Highlights

Market Capitalization 427.77M (small)

Floating Shares 47.35M

Current Price 3.95

Price To Earnings -3.54

Price To Revenue 7.11

Price To Book 1.76

Earnings Per Share -1.71

Payout Ratio 0%

Performance

Latest +2.6%

1 Month -5.95%

3 Months -39.32%

6 Months -2.95%

1 Year -10.84%

3 Years -87.13%

5 Years -85.15%

10 Years -85.15%

Benchmarks

Market Capitalization

154 / 368

Gross Profits

231 / 278

Total Revenue

164 / 300

Total Rank

298 / 368

Free Cashflow

251 / 352

Performance 5 years

248 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.